Adrenocorticotropin - A central trigger in immune responsiveness: Tonal inhibition of immune activation

被引:25
作者
Stefano, GB
Smith, EM
机构
[1] UNIV TEXAS, MED BRANCH, DEPT PSYCHIAT & BEHAV SCI, GALVESTON, TX 77555 USA
[2] UNIV TEXAS, MED BRANCH, DEPT MICROBIOL & IMMUNOL, GALVESTON, TX 77555 USA
关键词
D O I
10.1016/S0306-9877(96)90028-6
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Adrenocorticotropin is known for its key role in mediating neuroendocrine responses, especially in response to stress. Recently, it has been recognized to have direct immunomodulatory actions, most of which are suppressive. This is a widely conserved action which occurs in invertebrates and vertebrates. This conservation illustrates the fundamental nature of adrenocorticotropin's immunomodulatory action. Such a mechanism of action helps explain why the immunocytes themselves can serve as a source of adrenocorticotropin. Regulation of adrenocorticotropin production and action is complex and the result is an integration of multiple mechanisms. Serum adrenocorticotropin levels fluctuate in response to stimulatory and inhibitory factors. Further, peptidases can specifically process adrenocorticotropin into smaller active fragments, inactive peptides or into peptides with different activities. These proteolytic enzymes have a differential tissue and cellular distribution. Immune stimulating factors such as interleukin-l can overcome adrenocorticotropin inhibition and secondarily, block adrenocorticotropin production through the release of corticosteroids. With an endogenous presence and complex regulation it has been difficult to characterize adrenocorticotropin's role in the immune system. Here, we propose that adrenocorticotropin is a tonis regulator of immune response, i.e. it tonally inhibits immunocytes which undergo disinhibition as the result of exposure to stimulatory signals, e.g. cytokines, neuropeptides, etc. Thus, adrenocorticotropin appears to set the threshold for immunoactivation by controlling the degree of immunoexcitability.
引用
收藏
页码:471 / 478
页数:8
相关论文
共 59 条
[41]   IMMUNOSUPPRESSIVE EFFECTS OF CORTICOTROPIN AND MELANOTROPIN AND THEIR POSSIBLE SIGNIFICANCE IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
SMITH, EM ;
HUGHES, TK ;
HASHEMI, F ;
STEFANO, GB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (02) :782-786
[42]   HUMAN-LYMPHOCYTE PRODUCTION OF CORTICOTROPIN AND ENDORPHIN-LIKE SUBSTANCES - ASSOCIATION WITH LEUKOCYTE INTERFERON [J].
SMITH, EM ;
BLALOCK, JE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (12) :7530-7534
[43]   VIRUS-INDUCED CORTICOSTERONE IN HYPOPHYSECTOMIZED MICE - A POSSIBLE LYMPHOID ADRENAL AXIS [J].
SMITH, EM ;
MEYER, WJ ;
BLALOCK, JE .
SCIENCE, 1982, 218 (4579) :1311-1312
[44]   THE PRODUCTION AND ACTION OF ACTH-RELATED PEPTIDES IN INVERTEBRATE HEMOCYTES [J].
SMITH, EM ;
HUGHES, TK ;
LEUNG, MK ;
STEFANO, GB .
ADVANCES IN NEUROIMMUNOLOGY, 1991, 1 (01) :7-16
[45]  
SMITH EM, 1994, NEUROPEPTIDES IMMUNO, P28
[46]   MICROGLIA IN INVERTEBRATE GANGLIA [J].
SONETTI, D ;
OTTAVIANI, E ;
BIANCHI, F ;
RODRIGUEZ, M ;
STEFANO, ML ;
SCHARRER, B ;
STEFANO, GB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (19) :9180-9184
[47]   ENDOGENOUS MORPHINE AND RELATED OPIATES, A NEW CLASS OF CHEMICAL MESSENGERS [J].
STEFANO, GB ;
SCHARRER, B .
ADVANCES IN NEUROIMMUNOLOGY, 1994, 4 (02) :57-67
[48]   OPIATE-LIKE SUBSTANCES IN AN INVERTEBRATE, AN OPIATE RECEPTOR ON INVERTEBRATE AND HUMAN IMMUNOCYTES, AND A ROLE IN IMMUNOSUPPRESSION [J].
STEFANO, GB ;
DIGENIS, A ;
SPECTOR, S ;
LEUNG, MK ;
BILFINGER, TV ;
MAKMAN, MH ;
SCHARRER, B ;
ABUMRAD, NN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (23) :11099-11103
[49]  
STEFANO GB, 1983, CELL TISSUE RES, V230, P147
[50]   INHIBITORY EFFECT OF MORPHINE ON GRANULOCYTE STIMULATION BY TUMOR-NECROSIS-FACTOR AND SUBSTANCE-P [J].
STEFANO, GB ;
KUSHNERIK, V ;
RODRIQUEZ, M ;
BILFINGER, TV .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1994, 16 (04) :329-334